Wockhardt Medicines Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year,
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -202.77%
- Ebitda -202.32%
- Net Worth -201.66%
- Total Assets 2371.43%
About Wockhardt Medicines
Wockhardt Medicines Limited (WML) is a Public Limited Indian Non-Government Company incorporated in India on 25 March 2019 (Six years 0 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Stephen Dsouza, Sujatha Shetty, and Janet Gonsalves serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999MH2019PLC322942
-
Company No.
322942
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
25 Mar 2019
-
Date of AGM
05 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Pharma
Wockhardt Medicines Limited
Explore comprehensive data for Wockhardt Medicines Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Wockhardt Medicines?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Stephen Dsouza
|
Director | 25-Mar-2019 | Current |
|
Sujatha Shetty
|
Director | 30-Mar-2021 | Current |
|
Janet Gonsalves
|
Director | 01-Jun-2022 | Current |
Financial Performance of Wockhardt Medicines.
Wockhardt Medicines Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 202.77% decrease in profit. The company's net worth observed a substantial decline by a decrease of 201.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wockhardt Medicines?
In 2023, Wockhardt Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Merind LimitedStephen D'souza is a mutual person
-
Sharanya Chemicals And Pharmaceuticals Private Limited
Stephen D'souza and Sujatha Shetty are mutual person
-
Banneret Trading Private Limited
Stephen D'souza and Janet Gonsalves are mutual person
-
Wockhardt Holdings Limited
Stephen D'souza, Sujatha Shetty and 1 more are mutual person
-
Carol Info Services Limited
Stephen D'souza is a mutual person
-
Wockhardt Infrastructure Development Limited
Sujatha Shetty is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wockhardt Medicines?
Unlock and access historical data on people associated with Wockhardt Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wockhardt Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wockhardt Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Wockhardt Medicines
Recent activity within the organization
-
Annual General Meeting
Wockhardt Medicines Limited last Annual general meeting of members was held on 05 Sep 2023 as per latest MCA records.
-
Balance Sheet
Wockhardt Medicines Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
-
Director Appointment
Janet Gonsalves was appointed as a Director was appointed as a Director on 01 Jun 2022 & has been associated with this company since 2 years 9 months .
-
Director Appointment
Sujatha Shashikant Shetty was appointed as a Director was appointed as a Director on 30 Mar 2021 & has been associated with this company since 3 years 11 months .
-
Director Appointment
Stephen Sabbas Dsouza was appointed as a Director was appointed as a Director on 25 Mar 2019 & has been associated with this company since 6 years .
-
Company Incorporation
Wockhardt Medicines Limited was registered on 25 Mar 2019 with Roc Mumbai & aged 6 years as per MCA records.
Recent News, Updates & Announcement
-
-
-
Wockhardt Q1 net loss narrows to Rs 45 crore.
The company had posted a net loss of Rs 89.18 crore in the same period a year ago. .
-
New antibiotic drugs under development to have positive impact in future: Wockhardt's Khorakiwala.
"I believe that the development work on these drugs today will shape the global war on Antimicrobial Resistance (AMR) tomorrow," he added..
-
Buyout giants in talks with Wockhardt for domestic formulations business.
The individual suitors have indicated that they are interested in buying at least 51% stake in a deal that could value the biz at Rs 4,000-4,500 crore..
-
Wockhardt's Aurangabad Bioequivalence Centre Receives Zero Observations from USFDA, Boosting Chances for New Drug Approvals.
Wockhardt's bioequivalence centre in Aurangabad, Maharashtra received zero observations from the USFDA after an inspection. This means they followed all the rules and will likely get approvals for their new drugs. #Winning #USFDA #ZeroObservations #Bioequivalence #Wockhardt.
Frequently asked questions
-
What is the Incorporation or founding date of Wockhardt Medicines Limited?
Wockhardt Medicines Limited was incorporated on 25 Mar 2019.
-
What is authorized share capital and paid-up capital of Wockhardt Medicines Limited?
The authorized share capital of Wockhardt Medicines Limited is ₹ 1.00 M and paid-up capital is ₹ 0.50 M.
-
Who are the current board members & directors of Wockhardt Medicines Limited?
Currently 3 directors are associated with Wockhardt Medicines Limited.
- Stephen Sabbas Dsouza
- Sujatha Shashikant Shetty
- Janet Gonsalves
-
What is the registered address of Wockhardt Medicines Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Wockhardt Medicines Limited is A/501 5Th Floor Kanakia Zillion Next To Kurla Bus Depot, India, Mumbai, Maharashtra, 400070.
-
What is the corporate identification number (CIN) and company number of Wockhardt Medicines Limited?
The corporate identification number (CIN) of Wockhardt Medicines Limited is U74999MH2019PLC322942 and the company number is 322942 as per Ministry of Corporate Affairs (MCA).
-
What is the official website of Wockhardt Medicines Limited?
The Official website of Wockhardt Medicines Limited is https://www.wockhardt.com
-
What change has been observed in the net worth of Wockhardt Medicines Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Wockhardt Medicines Limited has experienced an downturn of -201.66%.
-
When was the last Balance Sheet of Wockhardt Medicines Limited filed with the ROC?
The most recent Balance Sheet for Wockhardt Medicines Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
-
SA
Shivasubramanian ADirector -
SN
Shobhana NagwekarDirector